Malignant pleural disease: Diagnosis by using diffusion-weighted and dynamic contrast-enhanced MR imaging - Initial experience

Radiology

Volumn 263, Issue 3, 2012, Pages 884-892

  Coolen, Johan ^a   De Keyzer, Frederik ^a   Nafteux, Philippe ^a   De Wever, Walter ^a   Dooms, Christophe ^a   Vansteenkiste, Johan ^a   Roebben, Ilse ^a   Verbeken, Eric ^a   De Leyn, Paul ^a   Van Raemdonck, Dirk ^a   Nackaerts, Kristiaan ^a   Dymarkowski, Steven ^a   Verschakelen, Johny ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; LUNG ADENOCARCINOMA; MALE; MALIGNANT PLEURA DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEURA BIOPSY; PLEURA DISEASE; PLEURA MESOTHELIOMA; PLEURISY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SARCOMATOID CARCINOMA; SENSITIVITY AND SPECIFICITY; WHOLE BODY PET;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PLEURAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; THORACOSCOPY; WHOLE BODY IMAGING;

EID: 84862496894     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12110872     Document Type: Article

References (38)

1. Bonomo L, Feragalli B, Sacco R, Merlino B, Storto ML. Malignant pleural disease. Eur J Radiol 2000;34(2):98-118. (Pubitemid 30389675)
2. Aisner J. Current approach to malignant mesothelioma of the pleura. Chest 1995;107(6 suppl):332S-344S.
3. Lee TT, Everett DL, Shu HK, et al. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2002;124(6):1183-1189. (Pubitemid 35417006)
4. Tsao AS, Wistuba I, Roth JA, Kindler HL. Malignant pleural mesothelioma. J Clin Oncol 2009;27(12):2081-2090.
5. Metintas M, Ak G, Parspour S, et al. Local recurrence of tumor at sites of intervention in malignant pleural mesothelioma. Lung Cancer 2008;61(2):255-261.
6. Scherpereel A, Astoul P, Baas P, et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J 2010;35(3):479-495.
7. Metintas M, Ucgun I, Elbek O, et al. Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases. Eur J Radiol 2002;41(1):1-9. (Pubitemid 34002983)
8. Wang ZJ, Reddy GP, Gotway MB, et al. Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET. Radio-Graphics 2004;24(1):105-119. (Pubitemid 38134597)
9. Kawashima A, Libshitz HI. Malignant pleural mesothelioma: CT manifestations in 50 cases. AJR Am J Roentgenol 1990;155(5):965-969. (Pubitemid 20356989)
10. Sahin AA, Cöplü L, Selçuk ZT, et al. Malignant pleural mesothelioma caused by environmental exposure to asbestos or erionite in rural Turkey: CT findings in 84 patients. AJR Am J Roentgenol 1993;161(3):533-537. (Pubitemid 23268672)
11. Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000;41(8):1369-1379. (Pubitemid 30643379)
12. Erasmus JJ, Truong MT, Smythe WR, et al. Integrated computed tomographypositron emission tomography in patients with potentially resectable malignant pleural mesothelioma: staging implications. J Thorac Cardiovasc Surg 2005;129(6):1364-1370. (Pubitemid 40804856)
13. Jaruskova M, Belohlavek O. Role of FDGPET and PET/CT in the diagnosis of prolonged febrile states. Eur J Nucl Med Mol Imaging 2006;33(8):913-918. (Pubitemid 44127440)
14. Fujimoto K. Usefulness of contrast-enhanced magnetic resonance imaging for evaluating solitary pulmonary nodules. Cancer Imaging 2008;8:36-44. (Pubitemid 351517295)
15. Yi CA, Jeon TY, Lee KS, et al. 3-T MRI: usefulness for evaluating primary lung cancer and small nodules in lobes not containing primary tumors. AJR Am J Roentgenol 2007;189(2):386-392. (Pubitemid 47195924)
16. Thoeny HC, De Keyzer F. Extracranial applications of diffusion-weighted magnetic resonance imaging. Eur Radiol 2007;17(6):1385-1393. (Pubitemid 46767586)
17. Kwee TC, Takahara T, Ochiai R, Nievelstein RA, Luijten PR. Diffusion-weighted wholebody imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 2008;18(9):1937-1952.
18. Kono R, Fujimoto K, Terasaki H, et al. Dynamic MRI of solitary pulmonary nodules: comparison of enhancement patterns of malignant and benign small peripheral lung lesions. AJR Am J Roentgenol 2007;188(1):26-36. (Pubitemid 46012486)
19. Yamamuro M, Gerbaudo VH, Gill RR, Jacobson FL, Sugarbaker DJ, Hatabu H. Morphologic and functional imaging of malignant pleural mesothelioma. Eur J Radiol 2007;64(3):356-366. (Pubitemid 350116492)
20. Giesel FL, Bischoff H, von Tengg-Kobligk H, et al. Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a feasibility study of noninvasive assessment, therapeutic follow-up, and possible predictor of improved outcome. Chest 2006;129(6):1570-1576. (Pubitemid 43894988)
21. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988;168(2):497-505.
22. Bammer R. Basic principles of diffusion-weighted imaging. Eur J Radiol 2003;45(3):169-184. (Pubitemid 36197713)
23. Inan N, Arslan A, Akansel G, Arslan Z, Elemen L, Demirci A. Diffusion-weighted MRI in the characterization of pleural effusions. Diagn Interv Radiol 2009;15(1):13-18.
24. Luna A, Sánchez-Gonzalez J, Caro P. Diffusion-weighted imaging of the chest. Magn Reson Imaging Clin N Am 2011;19(1):69-94.
25. Giesel FL, Choyke PL, Mehndiratta A, et al. Pharmacokinetic analysis of malignant pleural mesothelioma: initial results of tumor microcirculation and its correlation to microvessel density (CD-34). Acad Radiol 2008;15(5):563-570. (Pubitemid 351509763)
26. Mehndiratta A, Knopp MV, Zechmann CM, et al. Comparison of diagnostic quality and accuracy in color-coded versus gray-scale DCE-MR imaging display. Int J CARS 2009;4(5):457-462.
27. Gill RR, Umeoka S, Mamata H, et al. Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes. AJR Am J Roentgenol 2010;195(2):W125-W130.
28. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. Pleural mesothelioma. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC cancer staging manual. 7th ed. New York, NY: Springer, 2007; 271-277.
29. Husain AN, Colby TV, Ordóñez NG, et al. Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 2009;133(8):1317-1331.
30. Rosenbaum SJ, Lind T, Antoch G, Bockisch A. False-positive FDG PET uptake: the role of PET/CT. Eur Radiol 2006;16(5):1054-1065.
31. Flores RM, Akhurst T, Gonen M, Larson SM, Rusch VW. Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2003;126(1):11-16. (Pubitemid 36909936)
32. Heelan RT, Rusch VW, Begg CB, Panicek DM, Caravelli JF, Eisen C. Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. AJR Am J Roentgenol 1999;172(4):1039-1047. (Pubitemid 29505636)
33. Ahmadzadehfar H, Palmedo H, Strunk H, Biersack HJ, Habibi E, Ezziddin S. False positive 18F-FDG-PET/CT in a patient after talc pleurodesis. Lung Cancer 2007;58(3):418-421. (Pubitemid 350051500)
34. Sager S, Ergul N, Ciftci H, Cermik TF. False positive (18)F-FDG-PET/CT findings in a patient with talc pleurodesis. Hell J Nucl Med 2010;13(2):179-180.
35. Thoeny HC, De Keyzer F, Vandecaveye V, et al. Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging. Radiology 2005;237(2):492-499. (Pubitemid 41507886)
36. Taouli B, Thakur RK, Mannelli L, et al. Renal lesions: characterization with diffusionweighted imaging versus contrast-enhanced MR imaging. Radiology 2009;251(2):398-407.
37. Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology 2010;254(1):47-66.
38. Lyng H, Haraldseth O, Rofstad EK. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 2000;43(6):828-836. (Pubitemid 30387603)